×
For best experience we recommend to activate Javascript in your browser.
UBE2J1 antibody
The Mouse Monoclonal anti-UBE2J1 antibody has been validated for WB, IHC and FACS. It is suitable to detect UBE2J1 in samples from Human, Mouse, Rat, Monkey and Dog. There is 1 publication available.
Quick Overview for UBE2J1 antibody (ABIN2734850)
Target
See all UBE2J1 Antibodies
UBE2J1
(Ubiquitin-Conjugating Enzyme E2, J1, U (UBE2J1))
Reactivity
All reactivities for UBE2J1 antibodies
Human, Mouse, Rat, Monkey, Dog
Host
All hosts for UBE2J1 antibodies
Mouse
Clonality
All clonalities for UBE2J1 antibodies
Monoclonal
Conjugate
All conjugates for UBE2J1 antibodies
This UBE2J1 antibody is un-conjugated
Application
All applications for UBE2J1 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Flow Cytometry (FACS)
Clone
OTI3D1
Product Details anti-UBE2J1 Antibody
(hide)
Purification
Purified from mouse ascites fluids by affinity chromatography
Immunogen
Full length human recombinant protein of human UBE2J1(NP_057105) produced in HEK293T cell.
Isotype
IgG2a
Alternatives
(show)
anti-Ubiquitin-Conjugating Enzyme E2, J1, U (UBE2J1) (N-Term) antibody
UBE2J1
Reactivity: Human, Mouse, Rat, Guinea Pig, Monkey, Rabbit, Pig
WB, IHC, IHC (p)
Host: Rabbit
Polyclonal
unconjugated
Application Details
(hide)
Application Notes
WB 1:500~2000, IHC 1:150, FLOW 1:100,
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
References for anti-UBE2J1 antibody (ABIN2734850)
(hide)
Wang, Wang, Huang, Zhang, Zhu, Pei, Cheng, Sun, Wang, Jin, Zhao et al. : "Enterovirus 71 protease 2Apro and 3Cpro differentially inhibit the cellular endoplasmic reticulum-associated degradation (ERAD) pathway via distinct mechanisms, and enterovirus 71 hijacks ERAD ... " in: PLoS pathogens , Vol. 13 , Issue 10 , pp. e1006674 , (2017 ) (PubMed ).
Target Details for UBE2J1
(hide)
Target
UBE2J1
(Ubiquitin-Conjugating Enzyme E2, J1, U (UBE2J1))
Alternative Name
UBE2J1
Molecular Weight
35 kDa
NCBI Accession
NM_016021
HGNC
51465
Recently viewed
(hide)
Chat with us , powered by LiveChat